Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413).
about
Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Clinical outcomes of overlappi ...... .gov identifier: NCT02298413).
@en
type
label
Clinical outcomes of overlappi ...... .gov identifier: NCT02298413).
@en
prefLabel
Clinical outcomes of overlappi ...... .gov identifier: NCT02298413).
@en
P2093
P2860
P50
P356
P1476
Clinical outcomes of overlappi ...... s.gov identifier: NCT02298413)
@en
P2093
Alessandro Colombo
Alessandro Durante
Alfonso Ielasi
Annamaria Nicolino
Attilio Varricchio
Chiara Rovera
Francesco Pisano
Gabriele Gabrielli
Gabriele Tumminello
P2860
P304
P356
10.1002/CCD.27095
P577
2017-05-13T00:00:00Z